Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Aug;57(8):813-21.
doi: 10.1136/jcp.2003.014043.

Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence

T Hamada  1 , S Matsukita, M Goto, S Kitajima, S K Batra, T Irimura, K Sueyoshi, K Sugihara, S Yonezawa
Affiliations

Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence

T Hamada et al. J Clin Pathol. 2004 Aug.

Abstract

Background: Pleomorphic adenoma of the salivary gland (PA) is essentially a benign neoplasm. However, patients with recurrent PA are difficult to manage. There are rare reports on useful immunohistochemical markers to detect a high risk of recurrence when the primary lesions are resected.

Aims: To find a new marker to predict the recurrence of PA.

Methods: Primary lesions of PA were collected from nine patients showing subsequent recurrence and from 40 patients without recurrence during at least 10 years of follow up of the disease. Paraffin wax embedded tumour samples of the two groups were examined for the expression profiles of MUC1 (differentially glycosylated forms), MUC2, MUC4, MUC5AC, and MUC6 using immunohistochemistry. Several clinicopathological factors were also examined.

Results: In univariate analysis of the factors examined, MUC1/DF3 high expression (more than 30% of the neoplastic cells stained) in the primary lesions was seen more frequently in patients with recurrence (four of nine) than in those without recurrence (three of 40; p = 0.011). Larger tumour size (more than 3.0 cm) of the primary PA was also a significant (p = 0.035) risk factor for the recurrence of PA. In multivariate analysis, only high expression of MUC1/DF3 was found to be a significant independent risk factor for the recurrence of PA (p = 0.021).

Conclusions: Expression of MUC1/DF3 in PA is a useful marker to predict its recurrence. Those patients with PA showing positive MUC1/DF3 expression should be followed up carefully.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Primary pleomorphic adenoma of the salivary gland in a patient with subsequent recurrence. (A) The tumour cells (right side) were separated from the normal gland (left side) by a thin capsule (haematoxylin and eosin staining). (B) MUC1/DF3 was strongly expressed in the tumour cells. In the normal gland, low expression was seen at the surface of the ductal cells but not in the acinar cells. (C) MUC2, (D) MUC4, (E) MUC5AC, and (F) MUC6 were expressed in the intralobular ducts of the normal salivary gland (left side), but were not expressed in the tumour cells (right side). (D) MUC4 expression in the normal ducts was relatively intense.
Figure 2
Figure 2
MUC1 expression was occasionally seen in the capsular invasion areas. (A) haematoxylin and eosin staining. (B) MUC/DF3 immunohistochemistry.
See this image and copyright information in PMC

References

    1. Buchman C, Stringer SP, Mendenhall WM, et al. Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence. Laryngoscope 1994;104:1231–4. - PubMed
    1. Henriksson G, Westrin KM, Carlsoo B, et al. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer 1998;82:617–20. - PubMed
    1. McGurk M, Renehan A, Gleave EN, et al. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg 1996;83:1747–9. - PubMed
    1. Natvig K, Soberg R. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11–25 year follow-up study. Head Neck 1994;16:213–17. - PubMed
    1. Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol 1995;104:100–4. - PubMed

Publication types

MeSH terms